Nature Publishes Promising Results on Treatment of First Patient in Genetix Pharmaceuticals, Inc.’s Phase 1/2 Beta-Thalassemia Study
9/15/2010 10:30:15 AM
More...
|
Genetix Pharmaceuticals, Inc. Renamed bluebird bio; Announces Appointment of Nick Leschly as Chief Executive Officer
9/10/2010 7:20:03 AM
More...
|
Genetix Pharmaceuticals, Inc. Appoints Mitchell Finer, Ph.D. as Chief Scientific Officer
3/12/2010 9:26:02 AM
More...
|
Genetix Pharmaceuticals, Inc. Secures $35 Million in Series B Funding
3/12/2010 6:48:22 AM
More...
|
Genetix Pharmaceuticals, Inc. Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD) In Partnership with INSERM
11/12/2009 11:07:52 AM
More...
|
Genetix Pharmaceuticals, Inc. Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD)
11/6/2009 9:21:54 AM
More...
|
Genetix Pharmaceuticals, Inc. Appoints President of U.S. Operations
1/28/2008 11:54:52 AM
More...
|
James A. Geraghty Joins Genetix Pharmaceuticals, Inc. Board Of Directors
10/19/2005 5:12:52 PM
More...
|
Genetix Pharmaceuticals, Inc. Raises $12 Million To Fund Gene Therapy
10/19/2005 5:11:46 PM
More...
|